Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for preparing (+)-(S)-clopidogrel hydrogen sulfate pure crystal type I

A technology of clopidogrel bisulfate and clopidogrel free base, which is applied in the field of production and preparation of major cardiovascular and cerebrovascular drugs, and can solve problems such as difficulty in judging products

Inactive Publication Date: 2013-01-16
CRYSTAL PHARMATECH CO LTD
View PDF11 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Due to the overlapping of infrared absorption peaks, it is often difficult to judge whether the product contains a small amount of crystal form II without a reasonable quantitative analysis of the spectrum using chemometric methods

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing (+)-(S)-clopidogrel hydrogen sulfate pure crystal type I
  • Method for preparing (+)-(S)-clopidogrel hydrogen sulfate pure crystal type I
  • Method for preparing (+)-(S)-clopidogrel hydrogen sulfate pure crystal type I

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0060] Embodiment 1 Preparation of clopidogrel bisulfate crystal form I

[0061] Replace the air in the crystallizer with nitrogen; add a solution of clopidogrel free base in anisole (6ml, concentration 100mg / ml) and sulfuric acid in methyl isobutyl ketone (2.4ml, concentration 77.1mg / ml) in parallel with a pump , about 1.0eq), added within 0.5 hours; added 0.1g clopidogrel bisulfate crystal form I as a seed crystal; cooled the system to -10°C; stirred at -10°C for 0.25 hours; at -10°C Next, a solution of clopidogrel free base in anisole (24ml, concentration 100mg / ml) and sulfuric acid in methyl isobutyl ketone (9.6ml, 1.0eq, concentration 77.1mg / ml) were added in parallel by pump for 5 hours Add 0.1g clopidogrel bisulfate crystal form I as a seed crystal; raise the temperature to 40°C (0.3°C / min); keep the temperature at 40°C for 1 hour; cool down to 5°C, and hold the temperature for 3 hours, A solid-liquid slurry was obtained; the resulting solid-liquid slurry was filtered ...

Embodiment 2

[0063] Example 2 Preparation of Clopidogrel Hydrogen Sulfate Form I

[0064] Replace the air in the crystallizer with nitrogen; add anisole solution of clopidogrel free base (5ml, concentration 50mg / ml) and sulfuric acid solution in tetrahydrofuran (2ml, about 1.0eq, concentration 38.6mg / ml) in parallel with a pump, Add within 5 minutes; add 0.02g of clopidogrel bisulfate crystal form I as a seed crystal; cool down the system to -15°C; stir at -15°C for 1 hour; at -15°C, add in parallel with a pump Anisole solution of clopidogrel free base (25ml, concentration 50mg / ml) and sulfuric acid solution in tetrahydrofuran (10ml, about 1.0eq, concentration 38.6mg / ml), within 5 hours; add 0.1g clopidogrel Bisulfate crystal form I is used as a seed crystal; the temperature is raised to 40°C; the temperature is kept at 40°C for 2 hours; the temperature is lowered to 5°C and the temperature is kept for 10 hours; the filter cake is filtered under reduced pressure; the filter cake is washed ...

Embodiment 3

[0065] Example 3 Preparation of Clopidogrel Hydrogen Sulfate Form I

[0066] Replace the air in the crystallizer with nitrogen; add 13.5ml anisole and 5.8ml tetrahydrofuran to the crystallizer; add 0.1g clopidogrel bisulfate crystal form I as crystal seed to the crystallizer; cool the system to 5 ℃, and stirred for 0.25 hours; at 5 ℃, the anisole solution of clopidogrel free base (15ml, concentration 200mg / ml) and tetrahydrofuran solution of sulfuric acid (5.64ml, 164.8mg / ml) were added in parallel with a pump, Added within 16 hours; add 0.1g clopidogrel bisulfate crystal form I as a seed crystal; raise the temperature of the system to 35°C (0.3°C / min); keep at 35°C for 0.5 hours, take a sample to measure XRPD, confirm that it is pure Crystal form I; lower the temperature to 5°C (2°C / min), and stir at constant temperature for 0.5 hours; filter under reduced pressure; wash the filter cake with ethyl acetate three times, each time using 10ml ethyl acetate, take samples for XRPD ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
Login to View More

Abstract

The invention provides a crystallizing technology for preparing a (+)-(S)-clopidogrel hydrogen sulfate pure crystal type I. The crystallizing technology comprises the following steps of: (1) preparing organic solution of clopidogrel free alkali; (2) preparing organic solution of sulfuric acid; (3) adding the organic solution of clopidogrel free alkali and the organic solvent of sulfuric acid into a crystallizing device in parallel; taking the clopidogrel hydrogen sulfate pure crystal type I as the seed crystal, and curing at a constant temperature, thus obtaining the solid-liquid size; and (4) filtering the solid-liquid size, washing and drying, thus obtaining the (+)-(S)-clopidogrel hydrogen sulfate pure crystal type I powder.

Description

technical field [0001] The invention relates to the production and preparation of important cardiovascular and cerebrovascular drugs. Specifically, it is a crystallization process for preparing (+)-(S)-clopidogrel hydrogensulfate pure crystal form I (hereinafter referred to as crystal form I). Background technique [0002] (+)-(S)-Clopidogrel bisulfate is a drug for the prevention and treatment of heart, brain and other arterial circulation disorders caused by high platelet aggregation. The chemical name of the drug molecule is (+)-(S)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5-yl)acetic acid Methyl bisulfate, the structure of which is shown below: [0003] [0004] This drug has a good curative effect and is in great demand; as the patent protection of its drug molecule and crystal form I expires, generic drug companies need to be able to prepare pure crystal form I of clopidogrel bisulfate with high reproducibility. Form I is a crystalline form of the pu...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D495/04
Inventor 王建周鹏张炎锋陈敏华
Owner CRYSTAL PHARMATECH CO LTD